New US biosimilars bill a disappointing distraction, says GPhA
The generic pharmaceutical industry has given short shrift to the latest congressional attempt to construct a viable approval pathway for biosimilars in the US.
Archives for March 26, 2008
PRA International and Premier Research – Clinical contract news
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving PRA International and Premier Research.
DSMB backs Medidur
Medidur has been deemed safe by the Data Safety Monitoring Board (DSMB) for continuation of Phase III clinical trials with no amendments to the protocol.
UK pharma industry set to lose business offshore
The pharmaceutical industry has lost confidence in the UK as a place to do business to an "alarming degree" and the situation is only set to deteriorate, reveals new research.
Rhodia starts to unravel Organics business
French group Rhodia has put its gradual retreat from a flagging fine chemicals business on a more formal footing by announcing the break-up of Rhodia Organics.
NPIL making business moves
India's Nicholas Piramal has announced several business moves of late, designed to enhance its position on the world stage.
Redpoint Bio receives taste sensor patent
Redpoint Bio has been issued with a patent for an assay technology which tests whether a compound enhances or inhibits the bitter or sweet taste of different ingredients, allowing the company to screen for flavour enchancing compounds.
Researchers achieve scalable fullerene production and separation
They showed promise in everything from drug delivery to the development of superconductive compounds, but so far fullerenes have been difficult to produce and purify in sufficiently large quantities for useful applications.